Gene therapy could prevent blindness

American regulators have approved a gene therapy that treats an ‘inherited form of vision loss’. In a first for gene therapy, the U.S. Food and Drug Administration (FDA) has backed the treatment, developed by Spark Therapeutics, called Luxturna. FDA Commissioner Scott Gottlieb said: “The approval marks another first in the field of gene therapy — both in how … Continue reading Gene therapy could prevent blindness